Share Email Print
cover

Proceedings Paper

Psoralen photobiology and photochemotherapy: perspectives and prospects
Author(s): Francis P. Gasparro
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

For nearly 40 years the field of psoralen photobiology has been focused on the effects of photoactivated 8-MOP on nuclear DNA. The results of these extensive studies are reviewed. In addition, new targets for modification are described. 8-MOP and UVA was first used to treat skin afflicted with two common dermatological disorders, vitiligo and psoriasis. More recently, several other disease have been treated using an extracorporeal form of this photochemotherapy in which the patient's blood is irradiated with UVA. Clinical results and possible modes of action are described.

Paper Details

Date Published: 21 January 1990
PDF: 14 pages
Proc. SPIE 10306, Future Directions and Applications in Photodynamic Therapy, 103060F (21 January 1990); doi: 10.1117/12.2283677
Show Author Affiliations
Francis P. Gasparro, Yale Univ. (United States)


Published in SPIE Proceedings Vol. 10306:
Future Directions and Applications in Photodynamic Therapy
Charles J. Gomer, Editor(s)

© SPIE. Terms of Use
Back to Top